Compare HCA Health Inc (HCA) vs Ross Stores, Inc. (ROST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Ross Stores, Inc. — how do they compare? HCA Health Inc trades at $451.09 (market cap $96.35B), while Ross Stores, Inc. trades at $222.41 (market cap $71.94B). The key difference: HCA Health Inc is the larger of the two by market cap, and Ross Stores, Inc. pays the higher dividend (0.79%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Ross Stores, Inc. for 48 Days on average.
| HCA | ROST | |
|---|---|---|
Market Cap | $96.35B | $71.94B |
Volume | 1,079,453 | 2,002,519 |
Sector | Health | Consumer Cyclical |
52-Week High | $545.13 | $255.23 |
52-Week Low | $361.32 | $147.71 |
Typical Hold Time | 76 Days | 48 Days |
Enterprise Value | $146.88B | $72.39B |
Dividend Yield | 0.7% | 0.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $445.01, up 1.33% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.60 billion in 2025, with net income of $6.78 billion, while valuation metrics like a P/E of 14.92 appear reasonable. The company announced a dividend of $0.78 and completed the acquisition of The College of Health Care Professions, signaling growth initiatives.
The outlook is positive, supported by analyst consensus with a $461.12 price target and 63% buy ratings, though risks include ongoing legal investigations and high debt levels. Earnings growth and operational efficiency remain key drivers for potential upside, but investors should monitor regulatory and competitive pressures.
Ross Stores (ROST) trades at $225.2, down 0.15% on the day, with a bearish technical signal but strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $2.66 surpassing the $1.95 forecast. Revenue grew to $21.13B in 2025, and net income margin improved to 10.85%. Analyst consensus is bullish with a $274.14 price target, though technical indicators show resistance near $226.
The outlook for ROST is positive due to robust earnings performance, store expansion initiatives, and strong profitability metrics like a 42.63% ROE. Risks include competitive pressures and rising costs, but institutional buying and a high analyst buy rating (63.83%) support upside potential. The stock presents a compelling opportunity for growth investors seeking value in the discount retail sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Ross Stores, Inc.
Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →
